secwatch.observer — SEC 8-K summary
======================================

Issuer:     GRI Bio, Inc. (GRI)
CIK:        0001824293
Form:       8-K
Filed at:   2025-12-12T23:59:59+00:00
Accession:  0001628280-25-056751
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GRI Bio closes $8.0M public offering of common stock and Series F warrants
--------------------------------------------------------------------------

- Offering of 10,666,667 shares (or equivalents) plus Series F warrants to buy same number at $0.75/share.
- Gross proceeds $8.0M; H.C. Wainwright acted as exclusive placement agent.
- Series F warrants exercisable immediately at $0.75, expire in five years; potential additional $8.0M if fully cash-exercised.
- Proceeds to fund product development, working capital, and general corporate purposes.
- Post-offering stockholders' equity exceeds $2.5 million, addressing Nasdaq continued listing requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/0001628280-25-056751-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1824293/000162828025056751/val-20251212.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-056751

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer